Novartis India Limited Stock price

Equities

NOVARTIND

INE234A01025

Pharmaceuticals

Delayed Bombay S.E. 05:28:49 2024-03-28 am EDT 5-day change 1st Jan Change
1,035 INR +0.41% Intraday chart for Novartis India Limited +1.47% +33.59%
Sales 2022 4B 47.97M Sales 2023 3.79B 45.43M Capitalization 13.96B 167M
Net income 2022 -37M -444K Net income 2023 1.03B 12.4M EV / Sales 2022 2.41 x
Net cash position 2022 4.92B 59.05M Net cash position 2023 5.33B 63.93M EV / Sales 2023 2.28 x
P/E ratio 2022
-392 x
P/E ratio 2023
13.5 x
Employees 67
Yield 2022
1.69%
Yield 2023
1.77%
Free-Float 27.17%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.21%
1 week+1.47%
Current month+9.53%
1 month+7.92%
3 months+36.06%
6 months+44.81%
Current year+33.59%
More quotes
1 week
1 008.00
Extreme 1008
1 221.60
1 month
888.70
Extreme 888.7
1 221.60
Current year
768.60
Extreme 768.6
1 224.00
1 year
559.70
Extreme 559.7
1 224.00
3 years
538.05
Extreme 538.05
1 224.00
5 years
420.05
Extreme 420.05
1 224.00
10 years
420.05
Extreme 420.05
1 224.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 19-06-14
Director of Finance/CFO - 22-04-30
Compliance Officer - 22-04-26
Members of the board TitleAgeSince
Director/Board Member 76 06-01-27
Director/Board Member 64 20-06-21
Chairman - 08-07-31
More insiders
Date Price Change Volume
24-03-28 1,035 +0.41% 14 884
24-03-27 1,031 -1.47% 57,340
24-03-26 1,046 +1.31% 45,890
24-03-22 1,033 +1.45% 68,889
24-03-21 1,018 -0.61% 14,916

Delayed Quote Bombay S.E., March 28, 2024 at 05:28 am EDT

More quotes
Novartis India Limited is an India-based company that is engaged in the business of trading of pharmaceuticals. The Company's portfolio of medicines addresses various therapeutic needs, such as cardiovascular, eye care, immunology, metabolic, neuroscience, oncology, respiratory and organ transplant, to meet the medical needs of patients in India. In the bone and pain therapeutic area its brand is Voveran. In the transplantation immunology therapeutic area, the Company's brands include Simulect, Certican, Sandimmun, Neoral and Myfortic. In the neurosciences therapeutic area, its brands include Tegrital and Exelon.
More about the company
  1. Stock
  2. Equities
  3. Stock Novartis India Limited - Bombay S.E.